Table 9.
Group [a] | Time point | Assessment of bone structure (cavities) | Periosteal remodelling | Endosteal formation of new bone | Periosteal formation of new bone | Periimplant fibrosis | Total score |
---|---|---|---|---|---|---|---|
AX30 and ZEK100 | 3 | - | - | - | - | 0.002 | 0.003 |
AX30 and control | 3 | 0.008 | 0.002 | - | 0.002 | - | 0.002 |
ZEK100 and control | 3 | 0.002 | 0.003 | - | 0.003 | 0.002 | 0.002 |
AX30 and ZEK100 | 6 | - | - | - | - | - | - |
AX30 and control | 6 | 0.002 | 0.002 | - | 0.002 | 0.024 | 0.002 |
ZEK100 and control | 6 | 0.024 | 0.024 | - | 0.008 | 0.004 | 0.002 |
AX30 | 3 and 6 | - | - | - | - | < 0.001 | - |
ZEK100 | 3 and 6 | - | - | - | - | - | - |
[a] p-values at respective time points in the Mann-Whitney tests of the parameters with significant differences in the Kruskal-Wallis test